These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11472210)

  • 21. Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides.
    Williams TM; Sable R; Singh S; Vicente MGH; Jois SD
    Chem Biol Drug Des; 2018 Feb; 91(2):605-619. PubMed ID: 29052959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of cyclic and d-amino acids containing peptidomimetics for inhibition of protein-protein interactions of HER2-HER3.
    Pallerla S; Naik H; Singh S; Gauthier T; Sable R; Jois SD
    J Pept Sci; 2018 Feb; 24(2):. PubMed ID: 29436155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disabling receptor ensembles with rationally designed interface peptidomimetics.
    Berezov A; Chen J; Liu Q; Zhang HT; Greene MI; Murali R
    J Biol Chem; 2002 Aug; 277(31):28330-9. PubMed ID: 12011054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based approaches to inhibition of erbB receptors with peptide mimetics.
    Berezov A; Greene MI; Murali R
    Immunol Res; 2003; 27(2-3):303-8. PubMed ID: 12857977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer.
    You Y; Xu Z; Chen Y
    Drug Deliv; 2018 Nov; 25(1):448-460. PubMed ID: 29405790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.
    Yao X; Jiang J; Wang X; Huang C; Li D; Xie K; Xu Q; Li H; Li Z; Lou L; Fang J
    Breast Cancer Res Treat; 2015 Aug; 153(1):123-33. PubMed ID: 26253944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies.
    Zhang H; Wang Q; Montone KT; Peavey JE; Drebin JA; Greene MI; Murali R
    Exp Mol Pathol; 1999 Sep; 67(1):15-25. PubMed ID: 10493889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
    Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
    J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of a cyclic hexapeptide with sequence corresponding to murine tumor necrosis factor-(127-132) as a novel potential antitumor agent.
    Sheh L; Cheng JY; Kuan YH; Chen CF
    Int J Pept Protein Res; 1990 Aug; 36(2):104-8. PubMed ID: 2272746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Ultrasound-Triggered Phase Transition Nanodroplets for Her2-Overexpressing Breast Cancer Diagnosis and Gene Transfection.
    Gao D; Gao J; Xu M; Cao Z; Zhou L; Li Y; Xie X; Jiang Q; Wang W; Liu J
    Mol Pharm; 2017 Apr; 14(4):984-998. PubMed ID: 28282145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
    Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
    Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A SPR strategy for high-throughput ligand screenings based on synthetic peptides mimicking a selected subdomain of the target protein: a proof of concept on HER2 receptor.
    Monfregola L; Vitale RM; Amodeo P; De Luca S
    Bioorg Med Chem; 2009 Oct; 17(19):7015-20. PubMed ID: 19733086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New small
    Sabahnoo H; Noaparast Z; Abedi SM; Hosseinimehr SJ
    Eur J Med Chem; 2017 Feb; 127():1012-1024. PubMed ID: 27842890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.
    Shepard HM; Lewis GD; Sarup JC; Fendly BM; Maneval D; Mordenti J; Figari I; Kotts CE; Palladino MA; Ullrich A
    J Clin Immunol; 1991 May; 11(3):117-27. PubMed ID: 1679763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
    Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, radiolabeling and in vitro and in vivo characterization of tumor-antigen- and antibody-derived peptides for the detection of breast cancer.
    Okarvi SM; Jammaz IA
    Anticancer Res; 2009 Apr; 29(4):1399-409. PubMed ID: 19414394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
    Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
    J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design.
    Qiao C; Lv M; Li X; Geng J; Li Y; Zhang J; Lin Z; Feng J; Shen B
    J Biomol Struct Dyn; 2013; 31(5):511-21. PubMed ID: 23003339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
    Polakova K; Plaksin D; Chung DH; Belyakov IM; Berzofsky JA; Margulies DH
    J Immunol; 2000 Nov; 165(10):5703-12. PubMed ID: 11067928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.